Skip to main content
Premium Trial:

Request an Annual Quote

Labcyte, U of Helsinki Extend Collaboration

NEW YORK (GenomeWeb) – Labcyte today announced it has extended its collaboration with the University of Helsinki's Institute for Molecular Medicine Finland (FIMM) to use the firm's Echo liquid handling technology for personalized oncology.

Under the terms of the collaboration, FIMM's High Throughput Biomedicine Unit will test the firm's latest liquid handlers in genomic and proteomic applications downstream of drug sensitivity testing, and incorporate the technology into a range of workflows including high-content screening, reverse-phase protein arrays, next-generation sequencing, RNA sequencing, gene expression analysis, and genotyping.

Labcyte's acoustic liquid handling technology uses sound waves to transfer reagents, providing faster and more accurate results than traditional methods, the firm said in a statement.

"The Echo liquid handlers have been essential to pushing forward with multiple programs at FIMM, the biggest being our personalized cancer treatment program, which is totally reliant on having acoustic dispensers," said Krister Wennerberg, head of the High Throughput Biomedicine Unit at FIMM, said in a statement.

Labcyte's collaboration with FIMM for personalized medicine applications began in 2013.

The Scan

Lung Cancer Response to Checkpoint Inhibitors Reflected in Circulating Tumor DNA

In non-small cell lung cancer patients, researchers find in JCO Precision Oncology that survival benefits after immune checkpoint blockade coincide with a dip in ctDNA levels.

Study Reviews Family, Provider Responses to Rapid Whole-Genome Sequencing Follow-up

Investigators identified in the European Journal of Human Genetics variable follow-up practices after rapid whole-genome sequencing.

BMI-Related Variants Show Age-Related Stability in UK Biobank Participants

Researchers followed body mass index variant stability with genomic structural equation modeling and genome-wide association studies of 40- to 72-year olds in PLOS Genetics.

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.